Literature DB >> 5490473

Human pharmacokinetics of cephalexin.

T Bergan, T Midtvedt, J Erikssen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5490473     DOI: 10.1159/000136146

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  6 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin.

Authors:  Yi Ding; Yan-Yan Jia; Fan Li; Wen-Xing Liu; Cheng-Tao Lu; Yan-Rong Zhu; Jing Yang; Li-Kun Ding; Lin Yang; Ai-Dong Wen
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 3.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Effectiveness and tolerance of cephalexin in children.

Authors:  H Helwig; H Kunz; C Hueppchen
Journal:  Z Kinderheilkd       Date:  1972

5.  Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium.

Authors:  R V McCloskey; E E Terry; A W McCracken; M J Sweeney; M F Forland
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

6.  Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  Mol Pharm       Date:  2014-03-28       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.